* Note: Prices are in Million (M) USD.
Description:
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $1,122 M
Debt : $1,400 M
EBITDA : $326 M
Net Debt (Debt - Cash): $278 M
Since Net Debt is covered by EBITDA within 1 year, 3 points assigned.
This criteria used industry in which company operates:
Sector: Healthcare
Industry: Medical devices
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 69.83
Since Forward PE Ratio is greater than 35, 0 point assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Using last 20 overlapping fiscal years (max 20).Average Free Cash Flow: $-30 M
Average Revenue: $529 M
Revenue Converted To Free Cash Flow (%): -5.7%
Since Free Cash Flow (FCF) to Revenue percentage is non-positive, 0 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $2,072 M
Revenue 4 Years Ago (2020-12-31): $904 M
Last 5 Years Average Revenue Growth: 26%
Since Revenue Growth is greater than 20, 5 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $74 M
Share Count 5 Years Ago (2020-12-31): $66 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $5.22
Trailing 12-Month Earnings Per Share (EPS): $4.45
Average Earnings Per Share (EPS): $4.84
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0%
Since Dividend Per Share is less than or equal to 0, 0 point assigned.
Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Using last 18 valid ROE years (max 20).Average ROE: -164.5%
Since Average ROE is non-positive, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $338
52-Week Low: $180
Threshold Price (15% Above 52-Week Low): $207
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $23,078 M
Since Market Cap is between 10B - 100B, 2 points assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 0.20% exposure of Total Portfolio.
Value-Trade has assigned 13 points to above Insulet Corporation (PODD) stock.
Fair Value PE
12, Industry Based PE
18, Growth Based PE
25.81, Risk-Free Anchored PE (25% MoS)
17.61. Based on these 4 values, average assigned is
18.35. Value-Trades has assined P/E value
18.35. An average (Current Year EPS + Next Year EPS) earning per share is
$4.835.
Fair value using multiple P/Es (blended): $88.74 (PE 18.35 × EPS $4.84)
So the Final Fair Value is: $88.74
